Shenzhen Salubris Pharmaceuticals saw the highest growth of 3.99% in patent filings and 0.99% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.49% and grants by 0.49%. GlobalData’s DataBook provides a comprehensive analysis of Shenzhen Salubris Pharmaceuticals‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Shenzhen Salubris Pharmaceuticals has been focused on protecting inventions in China(CN) with six publications in Q2 2024
The China(CN) Patent Office dominates the patent filings and grants with nearly 57% filings and 40% grants. The China(CN), European Patent Office(EPO), United States(US), and Denmark(DK) patent Office are among the top ten patent offices where Shenzhen Salubris Pharmaceuticals is filings its patents. Among the top granted patent authorities, Shenzhen Salubris Pharmaceuticals has 40% of its grants in China(CN), 20% in United States(US) and 20% in Finland(FI).
Bayer and Roche could be the strongest competitors for Shenzhen Salubris Pharmaceuticals
Patents related to addiction lead Shenzhen Salubris Pharmaceuticals's portfolio
Shenzhen Salubris Pharmaceuticals has the highest number of patents in addiction.in Q2 2024.
Rheumatoid arthritis related patents lead Shenzhen Salubris Pharmaceuticals portfolio followed by arthritis
Shenzhen Salubris Pharmaceuticals has highest number of patents in rheumatoid arthritis followed by arthritis.
For comprehensive analysis of Shenzhen Salubris Pharmaceuticals's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
